- Home
- CARM vs INBS Comparison
CARM vs INBS Comparison
Compare CARM & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- INBS
- Stock Information
- Founded
- CARM 2016
- INBS 2016
- Country
- CARM United States
- INBS United States
- Employees
- CARM N/A
- INBS N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- CARM Health Care
- INBS Health Care
- Exchange
- CARM Nasdaq
- INBS Nasdaq
- Market Cap
- CARM 7.7M
- INBS 8.7M
- IPO Year
- CARM N/A
- INBS N/A
- Fundamental
- Price
- CARM $0.19
- INBS $1.41
- Analyst Decision
- CARM Hold
- INBS
- Analyst Count
- CARM 5
- INBS 0
- Target Price
- CARM $0.90
- INBS N/A
- AVG Volume (30 Days)
- CARM 956.5K
- INBS 127.7K
- Earning Date
- CARM 05-13-2025
- INBS 05-13-2025
- Dividend Yield
- CARM N/A
- INBS N/A
- EPS Growth
- CARM N/A
- INBS N/A
- EPS
- CARM N/A
- INBS N/A
- Revenue
- CARM $19,964,000.00
- INBS $2,936,472.00
- Revenue This Year
- CARM N/A
- INBS $280.88
- Revenue Next Year
- CARM N/A
- INBS $126.26
- P/E Ratio
- CARM N/A
- INBS N/A
- Revenue Growth
- CARM 32.45
- INBS 3.87
- 52 Week Low
- CARM $0.14
- INBS $1.00
- 52 Week High
- CARM $1.90
- INBS $3.00
- Technical
- Relative Strength Index (RSI)
- CARM 44.76
- INBS 54.99
- Support Level
- CARM $0.14
- INBS $1.18
- Resistance Level
- CARM $0.20
- INBS $1.57
- Average True Range (ATR)
- CARM 0.02
- INBS 0.11
- MACD
- CARM 0.00
- INBS 0.03
- Stochastic Oscillator
- CARM 71.47
- INBS 60.98
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).